the EU framework programme for
research and innovation
The Multiannual Financial Framework 2014-2020:
1.
Smart & inclusive growth (€491bn)
Education,
Connecting Cohesion
Youth, Sport Europe
Competitive
Business SMEs
Horizon 2020
2. Sustainable growth, natural resources (€383bn)
3. Security and citizenship (€18.5bn)
4. Global Europe (€70bn)
5. Administration (€62.6bn)
Total:
€ 1,025bn
Impact of R&D on economic recovery
4.0
SE
FI
Average R&D investment, 2004-2009
3.5
3.0
DK
DE
AT
2.5
FR
2.0
BE
UK
NL
LU
1.5
CZ
IE
ES
PT
IT
EE
1.0
0.0
-5.0
PL
HU
EL
0.5
LV
-4.0
-3.0
-2.0
-1.0
RO
BG
0.0
LT
SK
CY
1.0
GDP growth, 2010
2.0
3.0
4.0
5.0
6.0
What is Horizon 2020?
•
•
•
Commission proposal for a 80 billion euro research and innovation funding programme
(2014-20)
Part of proposals for next EU budget, complementing Structural Funds, education, etc.
A core part of Europe 2020, Innovation Union & European Research Area:
– Responding to the economic crisis to invest in future jobs and growth
– Addressing peoples’ concerns about their livelihoods, safety and environment.
– Strengthening the EU’s global position in research, innovation and technology
What’s new?
•
A single programme bringing together three separate programmes/initiatives:
•
The 7th research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation
Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology
(EIT)
•
More innovation, from research to retail, all forms of innovation
•
Focus on societal challenges facing EU society, e.g. health, clean energy and transport
•
Simplified access, for all companies, universities, institutes in all EU countries and
beyond.
Three priorities of Horizon2020:
1 Excellent science
2 Industrial leadership
3 Societal challenges
Horizon 2020 and partnering
Public-Private Partnerships (PPPs):
•
•
•
Through Joint Technology Initiatives or other formal structures (§ 187.)
Via contractual arrangements, which provide inputs for work programmes
Only when criteria met, e.g. clear commitments from private partners
Public-Public Partnerships (P2Ps):
•
•
•
•
Through “ERA-Nets” for topping up individual calls/ actions (replacing current ERA-Net,
ERA-Net Plus, Inco-Net, Inno-net)
Through participation in joint programs between Member States (§ 185.)
Supporting agendas of Joint Programming Initiatives when in line with Horizon 2020
Only when criteria met, e.g. financial commitments of participating countries
European Innovation Partnerships
•
Not funding instruments, but for coordination with broader policies and programmes
Horizon 2020: indicative budget breakdown
EIT
1538€(+1628€)
Societal challenges
35892€
JRC/ Non-nuclear
2212€
Excellent science
27818€
Industrial leadership
20280€
TOTAL 87 740 M€
(*63-65 M€ for Dec. 2012)
(in current prices, based on the 80 Bn € proposal)
Priority 3 Societal challenges
Why:
• EU policy objectives
(climate, environment,
energy, transport etc)
cannot be achieved
without innovation
• Breakthrough solutions
come from multidisciplinary collaborations,
including social sciences &
humanities
• Promising solutions need
to be tested, demonstrated
and scaled up
Commission's proposal
SIMPLIFICATION
EU
Financial
Regulation
…ETC
SINGLE SET OF RULES
for Horizon 2020
Societal Challenge on Inclusive, innovative and
secure societies / Part 6.1.4. Closing the research
and innovation divide in Europe (I)
Significant regional disparities across Europe in research and
innovation performance need to be addressed. Measures will aim at
unlocking excellence and innovation and will be distinct,
complementary and synergistic with policies and actions of the
Cohesion policy Funds. They include:
• Linking emerging institutions, centres of excellence and innovative
regions in less developed Member States to international leading
counterparts elsewhere in Europe:
– measures include teaming of excellent research institutions and less developed
regions, staff exchanges, expert advice and assistance and the development of
joint strategies for the establishment of centres of excellence that may be
supported by the Cohesion policy funds in less developed regions.
– Building links with innovative clusters and recognising excellence in less
developed regions, including through peer reviews and awarding labels of
excellence to those institutions that meet international standards, will be
considered.
Societal Challenge on Inclusive, innovative and
secure societies / Part 6.1.4. Closing the research and
innovation divide in Europe (III)
• Supporting access to international networks for excellent
researchers and innovators who lack sufficient involvement in
European and international networks. This will include support
provided through COST and National Contact Points.
• Supporting the development and monitoring of smart specialisation
strategies. A policy support facility will be developed and policy
learning at regional level will be facilitated through international
evaluation by peers and best practice sharing.
Horizon 2020
– kwestie związane ze zdrowiem
Kwestie dotyczące zdrowia zostały szczegółowo zdefiniowane w Programie
Szczegółowym - części III – Wyzwania Społeczne. Tematyka zdrowia została
uwzględniona jako pierwsze wyzwanie społeczne, pn. „Health, demographic change
and wellbeing”.
W dokumencie podkreślono, że skuteczne działania na rzecz zapobiegania,
wczesnego wykrywania i zarządzania chorobą oraz leczenia opierają się na
fundamentalnym zrozumieniu jej przyczyn, przebiegu i skutków, jak również
czynników leżących u podstaw zdrowia i dobrego samopoczucia. Lepsze zrozumienie
zdrowia i choroby wymaga ścisłej współpracy w zakresie badań podstawowych,
klinicznych, epidemiologicznych i społecznogospodarczych.
Dokument podkreśla, że istotnym wyzwaniem społecznym jest dziś właściwa reakcja
na obciążenia systemu opieki zdrowotnej i społecznej wynikające ze starzejącego
się społeczeństwa.
Horizon 2020
– kwestie związane ze zdrowiem
Wśród wymienionych w dokumencie chorób, które wymagają szczególnej
uwagi, znajdują się:
 choroby układu krążenia, nowotwory,
 nadwaga i otyłość, choroby metaboliczne w tym cukrzyca,
 choroby neurologiczne, choroby neurodegeneracyjne, zaburzenia
zdrowia psychicznego,
 choroby rzadkie, choroby autoimmunologiczne,
 choroby reumatyczne i mięśniowo-szkieletowe,
 choroby zakaźne, w tym HIV / AIDS, gruźlica, malaria i choroby
wynikające z zaniedbania i ubóstwa.
MEMBERSHIP
Alliance for Biomedical Research in Europe
Horizon 2020: Time line
May 2011
Green Paper
Consultation
End 2011 – Parliament
and Council start
negotiations on
Commission’s
proposals
30th Nov 2011 Proposal
from the Commission to
the European Parliament
and Council
End 2013 – Adoption of
legislative acts by
Parliament and
European Council of
Ministers on H2020
December 2011
BioMed Alliance
engages the biomedical
community
Launch of first
calls under
H2020
The European Council for Health Research
(EuCHR) concept - a scientific-led strategic body that
can steer health research - was put forward by the
BioMed Alliance upon consultation with an eminent
group of scientists and policy experts who prepared
a concept paper that was endorsed by the European
biomedical community at large
The main argument for a EuCHR: Fostering innovation in Europa
by using contemporary evidence to bridge health research and
policy for the benefit of society
The Funders Forum will include
Member States, Charities and
other relevant parties. It will look
at
how funds could be combined and
complemented with EU
contributions to promote
synergies on specific purposes
(along the lines of the Joint Action
‘European Partnership for Action
Against Cancer’ WP8: coordination of research).
EuCHR : Key players
Commission
The European Commission is a key
partner and will implement the strategy
set by the SSB through the annual work
programmes. It will prepare calls, perform
the evaluation process and implement
funding. It will also participate in the
communication strategy.
Scientific Steering Board
Funders Platform
The Stakeholders Platform will have a
broad representation of all stakeholders in
the health research continuum, patients
included.
Structure and networking mechanisms
will need to be defined in order to optimize
the consultation process and the impact of
their input.
Programme Committee
Stakeholders Platform
The SSB will seek a much greater
involvement of the Member States
through the Programme
Committee during the preparation and
approval of the annual work
programmes.